Related Experiment Video
Updated: Apr 15, 2026
09:06
MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
523
MicroRNA Therapeutics: the Next Magic Bullet?
1Cardiovascular Division, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, CLS 907, Boston, MA 02215, USA. sdas@bidmc.harvard.edu.
Mini Reviews in Medicinal Chemistry
|March 27, 2015
Summary
MicroRNA therapeutics offer a promising approach to treating diseases by regulating gene expression. This review covers microRNA therapy, delivery methods, clinical trials, and challenges.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- MicroRNAs (miRNAs) are short, noncoding RNA molecules regulating gene expression.
- Over 1000 human miRNAs are known, controlling over 50% of mammalian genes.
- Dysregulated miRNA expression is linked to various diseases, presenting therapeutic targets.
Purpose of the Study:
- To review current knowledge on microRNA (miRNA) therapeutics.
- To discuss the utilization, delivery methods, and clinical applications of miRNA-based therapies.
- To identify and address current limitations in the field of miRNA therapy.
Main Methods:
- Literature review of current research on microRNA therapy.
- Analysis of miRNA delivery systems and their efficacy.
- Examination of ongoing clinical trials for miRNA-based treatments.
- Discussion of challenges and potential solutions in miRNA therapeutic development.
Main Results:
- MicroRNA therapy demonstrates potential for treating diseases by modulating gene expression.
- Various delivery methods are being explored to enhance miRNA stability and targeting.
- Several microRNA-based therapies are in clinical trials for conditions like cancer and cardiovascular diseases.
- Overcoming challenges in delivery and specificity is crucial for therapeutic success.
Conclusions:
- MicroRNA therapeutics represent a significant advancement in personalized medicine.
- Continued research and development are essential to fully realize the potential of miRNA-based treatments.
- Addressing delivery and stability issues will be key to the clinical translation of microRNA therapies.
Related Concept Videos
01:22MicroRNAs
24.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.8K
01:22MicroRNAs
4.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
01:22MicroRNAs
12.1K
12.1K
01:24Microbial Corrosion
69
Microbiologically Influenced Corrosion (MIC) is a significant form of material degradation caused by the metabolic activities of microorganisms. This phenomenon poses substantial challenges across various industries, including oil and gas, maritime, and water treatment sectors.MIC occurs when microorganisms, such as bacteria, archaea, and fungi, colonize metal surfaces, forming biofilms that alter the local electrochemical environment. These biofilms can lead to the production of corrosive...
69
01:29Microorganisms in Medicine and Therapeutics
1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
01:23RNA Interference
28.9K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.9K